“Immunosuppression is so much better, and we have fantastic new technology, and that’s what’s made all the difference,’’ says Irving L. Kron, a spokesman for the American Heart Association and a thoracic and cardiovascular surgeon at the University of Virginia Health System in Charlottesville. “There’s a really good chance that people will be around in 20 or more years.’’